Roland R Griffiths

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Palliative Care

Cross Sectional

Ejection Fraction

Advanced Cancer

Top Venues

Journal of psychopharmacology (Oxford, England)

Current topics in behavioral neurosciences

Translational psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Natalie Gukasyan, Roland R Griffiths, David B Yaden, Denis G Antoine, Sandeep M Nayak
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. Journal of psychopharmacology (Oxford, England) (2023)
Sandeep M Nayak, Manvir Singh, David B Yaden, Roland R Griffiths
Belief changes associated with psychedelic use. Journal of psychopharmacology (Oxford, England) (2022)
Mary M Sweeney, Sandeep Nayak, Ethan S Hurwitz, Lisa N Mitchell, T Cody Swift, Roland R Griffiths
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. PloS one 17 (8) (2022)
Natalie Gukasyan, Alan Kooi Davis, Frederick S Barrett, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Roland R Griffiths
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of psychopharmacology (Oxford, England) 36 (2) (2022)
David Bryce Yaden, Sandeep M Nayak, Natalie Gukasyan, Brian T Anderson, Roland R Griffiths
The Potential of Psychedelics for End of Life and Palliative Care. Current topics in behavioral neurosciences 56 (2022)
Manoj K Doss, Michal Považan, Monica D Rosenberg, Nathan D Sepeda, Alan K Davis, Patrick H Finan, Gwenn S Smith, James J Pekar, Peter B Barker, Roland R Griffiths, Frederick S Barrett
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational psychiatry 11 (1) (2021)
Roland R Griffiths, Ethan S Hurwitz, Alan Kooi Davis, Matthew W Johnson, Robert Jesse
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PloS one 14 (4) (2019)